強気
$650.45
シナリオ価格
$560.360
+13.505 (+2.41%)終値時点
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants.
IDEXX Laboratories Inc is a good buy right now due to its current price of $518, which is significantly lower than the average analyst price target of $670, indicating a potential upside of approximately 29%. Additionally, the company's forward P/E ratio of 31.45 suggests that it is trading at a reasonable valuation relative to its growth prospects, especially considering its recent earnings report that showed an EPS of 4.27, exceeding estimates by 8.10%.
KeyBanc
—
2026-10-12
KeyBanc
2026-10-12
目標株価
—
Barclays
$710
2026-08-11
Barclays
2026-08-11
目標株価
$710
Citi
$670
2026-08-05
Citi
2026-08-05
目標株価
$670
UBS
$620
2026-07-27
UBS
2026-07-27
目標株価
$620
Stifel
$564.42
2026-07-15
Stifel
2026-07-15
目標株価
$564.42
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Wall Street's Latest Ratings Overview

IDEXX Laboratories Schedules Q3 2026 Financial Results Release

IDEXX Expands Faecal Testing Platform for Parasite Detection

IDEXX Acquires CoVetAI to Enhance Diagnostic Capabilities

Director Lawrence D. Kingsley Sells 2,203 Shares of IDEXX Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. It also manufactures and sells human medical point-of-care diagnostic products. Its products and services include point-of-care veterinary diagnostic products, comprised of instruments, consumables, and rapid assay test kits. It also includes veterinary reference laboratory diagnostic and consulting services. It offers practice management systems, software and diagnostic imaging systems and services used by veterinarians. It also offers health monitoring, biological materials testing, laboratory diagnostic instruments, and services used by the biomedical research community. The Company provides diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants. It operates in the Healthcare sector (IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry).
IDEXX Laboratories Inc is a good buy right now due to its current price of $518, which is significantly lower than the average analyst price target of $670, indicating a potential upside of approximately 29%. Additionally, the company's forward P/E ratio of 31.45 suggests that it is trading at a reasonable valuation relative to its growth prospects, especially considering its recent earnings report that showed an EPS of 4.27, exceeding estimates by 8.10%.
10 analysts cover IDXX: 6 rate it Buy, 3 Hold and 1 Sell. The average price target is 792.78.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。